14 results for author:"Castellone M.D." in Literature citations
Results Customize
› Repeat search in UniProtKB (1)
| FOXM1 is a molecular determinant of the mitogenic and invasive phenotype of anaplastic thyroid carcinoma. Bellelli R., Castellone M.D., Garcia-Rostan G., Ugolini C., Nucera C., Sadow P.M., Nappi T.C., Salerno P., Cantisani M.C., Basolo F. et al. Endocr. Relat. Cancer 19:695-710(2012) · Mapped (3) |
| CD44 proteolysis increases CREB phosphorylation and sustains proliferation of thyroid cancer cells. De Falco V., Tamburrino A., Ventre S., Castellone M.D., Malek M., Manie S.N., Santoro M. Cancer Res. 72:1449-1458(2012) · Mapped (15) |
| Extracellular superoxide dismutase is a thyroid differentiation marker down-regulated in cancer. Laatikainen L.E., Castellone M.D., Hebrant A., Hoste C., Cantisani M.C., Laurila J.P., Salvatore G., Salerno P., Basolo F., Nasman J. et al. Endocr. Relat. Cancer 17:785-796(2010) · Mapped (3) |
| SOD3 reduces inflammatory cell migration by regulating adhesion molecule and cytokine expression. Laurila J.P., Laatikainen L.E., Castellone M.D., Laukkanen M.O. PLoS ONE 4:e5786-e5786(2009) · Mapped (8) |
| Biological role and potential therapeutic targeting of the chemokine receptor CXCR4 in undifferentiated thyroid cancer. De Falco V., Guarino V., Avilla E., Castellone M.D., Salerno P., Salvatore G., Faviana P., Basolo F., Santoro M., Melillo R.M. Cancer Res. 67:11821-11829(2007) · Mapped (2) |
| OPN/CD44v6 overexpression in laryngeal dysplasia and correlation with clinical outcome. Staibano S., Merolla F., Testa D., Iovine R., Mascolo M., Guarino V., Castellone M.D., Di Benedetto M., Galli V., Motta S. et al. Br. J. Cancer 97:1545-1551(2007) · Mapped (14) |
| A cell proliferation and chromosomal instability signature in anaplastic thyroid carcinoma. Salvatore G., Nappi T.C., Salerno P., Jiang Y., Garbi C., Ugolini C., Miccoli P., Basolo F., Castellone M.D., Cirafici A.M. et al. Cancer Res. 67:10148-10158(2007) · UniProtKB (1) |
| Robo4 signaling in endothelial cells implies attraction guidance mechanisms. Kaur S., Castellone M.D., Bedell V.M., Konar M., Gutkind J.S., Ramchandran R. J. Biol. Chem. 281:11347-11356(2006) · Mapped (4) |
| Overexpression of the cytokine osteopontin identifies aggressive laryngeal squamous cell carcinomas and enhances carcinoma cell proliferation and invasiveness. Celetti A., Testa D., Staibano S., Merolla F., Guarino V., Castellone M.D., Iovine R., Mansueto G., Somma P., De Rosa G. et al. Clin. Cancer Res. 11:8019-8027(2005) · Mapped (10) |
| Regulation of the transcriptional activity of c-Fos by ERK. A novel role for the prolyl isomerase PIN1. Monje P., Hernandez-Losa J., Lyons R.J., Castellone M.D., Gutkind J.S. J. Biol. Chem. 280:35081-35084(2005) · Mapped (14) |
| Osteopontin is overexpressed in human papillary thyroid carcinomas and enhances thyroid carcinoma cell invasiveness. Guarino V., Faviana P., Salvatore G., Castellone M.D., Cirafici A.M., De Falco V., Celetti A., Giannini R., Basolo F., Melillo R.M. et al. J. Clin. Endocrinol. Metab. 90:5270-5278(2005) · Mapped (10) |
| The RET/PTC-RAS-BRAF linear signaling cascade mediates the motile and mitogenic phenotype of thyroid cancer cells. Melillo R.M., Castellone M.D., Guarino V., De Falco V., Cirafici A.M., Salvatore G., Caiazzo F., Basolo F., Giannini R., Kruhoffer M. et al. J. Clin. Invest. 115:1068-1081(2005) · Mapped (11) |
| Autocrine activation of an osteopontin-CD44-Rac pathway enhances invasion and transformation by H-RasV12. Teramoto H., Castellone M.D., Malek R.L., Letwin N., Frank B., Gutkind J.S., Lee N.H. Oncogene 24:489-501(2005) · Mapped (15) |
| Tyrosine kinase oncoprotein, RET/PTC3, induces the secretion of myeloid growth and chemotactic factors. Russell J.P., Shinohara S., Melillo R.M., Castellone M.D., Santoro M., Rothstein J.L. Oncogene 22:4569-4577(2003) · Mapped (10) |